1. Home
  2. Live Updates
  3. Immunology research

Live Breaking News & Updates on Immunology research

Stay informed with the latest breaking news from Immunology research on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Immunology research and stay connected to the pulse of your community

Nucleome Therapeutics appoints Dr John Davis as Non-Executive Director of the Board and establishes Scientific Advisory Board of world-leading experts

Nucleome Therapeutics appoints Dr John Davis as Non-Executive Director of the Board and establishes Scientific Advisory Board of world-leading experts
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Rockefeller-university , New-york , United-states , Germany , Philadelphia , Pennsylvania , Heidelberg , Baden-wüberg , Cambridge , Cambridgeshire , United-kingdom , Palermo

Moonwalk Biosciences to Present Data Showcasing EpiRead™ and EpiWrite™ Next-Generation Multiplex Epigenetic Engineering Platform at ASGCT 2024

Moonwalk Biosciences to Present Data Showcasing EpiRead™ and EpiWrite™ Next-Generation Multiplex Epigenetic Engineering Platform at ASGCT 2024
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Maryland , United-states , Baltimore , American , Mike-varney , Feng-zhang , Rigel-kishton , Alex-aravanis , American-society-of-gene , Head-of-immunology-research , Broad-institute , Present-data-showcasing-epiread

Novel cell therapy treatments offer promise to immune-compromised children

WASHINGTON, April 18, 2024 (GLOBE NEWSWIRE) -- In a first-of-its-kind clinical trial, researchers found that intravenous therapies made from vir...

Maryland , United-states , Washington , California , Virginia , Patrick-hanley , Michael-keller , Catherine-bollard , Michael-pulsipher , Katie-shrader , Los-angeles , Instagram

Novel cell therapy treatments offer promise to immune-compromised children

Novel cell therapy treatments offer promise to immune-compromised children
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Michael-keller , Catherine-bollard , Patrick-hanley , Michael-pulsipher , Michaeld-keller , Children-national-hospital , Huntsman-cancer-institute , Translational-research-laboratory , Cell-therapy-consortium , Drug-administration , Deficiency-treatment-consortium , Children-national-cell-enhancement

Novel cell therapy treatments offer promise to immune-compromised children

Novel cell therapy treatments offer promise to immune-compromised children
eagletribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eagletribune.com Daily Mail and Mail on Sunday newspapers.

Washington , United-states , California , Virginia , Maryland , Catherine-bollard , Michael-pulsipher , Los-angeles , Patrick-hanley , Katie-shrader , Michael-keller , Huntsman-cancer-institute

Dr Raj Chovatiya Explains Oral JAK Inhibitor Monitoring Protocols for AD Treatment

Raj Chovatiya, MD, PhD, associate professor at the Rosalind Franklin University of Medicine and Science, described monitoring protocols for clinicians when using oral Janus kinase (JAK) inhibitors to treat patients with atopic dermatitis (AD).

Chicago , Illinois , United-states , Raj-chovatiya , Immunology-research , Rosalind-franklin-university-of-medicine , Rosalind-franklin-university , Medical-dermatology , Dr-raj-chovatiya , Jak-inhibitors , Atopic-dermatitis , Ad

Raj Chovatiya, MD, PhD: Takeaways from New Data on Vitiligo, Atopic Dermatitis, HS Treatments

This post-AAD interview with Chovatiya covered takeaways regarding recent data on upadacitinib for vitiligo, tapinarof for eczema, and lutikizumab for hidradenitis suppurativa.

Chicago , Illinois , United-states , San-diego , California , American , Raj-chovatiya , American-academy-of-dermatology , Immunology-research , Rosalind-franklin-university-chicago-medical-school , Medical-dermatology , Upadacitinib

Reflecting on Latest Updates in Psoriasis Research with Raj Chovatiya, MD, PhD

Chovatiya spoke in this post-AAD interview to some of the major takeaways in psoriasis research, highlighting deucravacitinib, bimekizumab, and other therapies.

Chicago , Illinois , United-states , American , Raj-chovatiya , American-academy-of-dermatology , Immunology-research , Rosalind-franklin-university-chicago-medical-school , Annual-meeting , Medical-dermatology , Psoriasis-area , Severity-index

Foods for mitigating allergies

Q. My seasonal allergies always get bad this time of year. Are there any foods I can eat or avoid to help ease my allergy symptoms?

University-of-florida , Immunology-research , European-journal , Clinical-nutrition , Food , Edicine , Ood-industry , Icrobiology , Iochemistry , Harmacology , Iology

Dr Raj Chovatiya Provides Evidence Supporting Oral JAK Inhibitor Use to Treat AD

Raj Chovatiya, MD, PhD, associate professor at the Rosalind Franklin University of Medicine and Science, provided current clinical evidence supporting the use of oral Janus kinase (JAK) inhibitors to treat patients with atopic dermatitis (AD).

Chicago , Illinois , United-states , Raj-chovatiya , Rosalind-franklin-university-of-medicine , Immunology-research , Rosalind-franklin-university , Medical-dermatology , Dr-raj-chovatiya , Jak-inhibitors , Atopic-dermatitis , Ad